Janney Montgomery Scott Downgrades Medifast (MED) to Neutral
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $11.44 --0%
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
4 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Janney Montgomery Scott downgraded Medifast (NYSE: MED) from Buy to Neutral, price target lowered from $27 to $17.
For more ratings news on Medifast click here and for the rating history of Medifast click here.
Shares of Medifast closed at $15.49 yesterday.
For more ratings news on Medifast click here and for the rating history of Medifast click here.
Shares of Medifast closed at $15.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Northcoast Downgrades ScanSource (SCSC) to Neutral
- Oppenheimer Downgrades AtaiBeckley Inc (ATAI) to Perform
Create E-mail Alert Related Categories
DowngradesRelated Entities
Janney Montgomery ScottSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
